Abstract: The prevalence of nosocomial infections is escalating due to the rise of antimicrobial-resistant ESKAPE pathogens, including Enterococcus species. This review explores the molecular intricacies governing biofilm formation in Enterococcus, shedding light on its persistent nature and implications for treatment. The study delves into genetic determinants, efflux pumps, and metabolic adaptations driving antibiotic resistance and biofilm resilience. Challenges in current therapeutic approaches are highlighted, emphasizing the need for precision medicine tailored to Enterococcus strains. The review presents emerging therapeutic strategies, including bacteriophage therapy and engineered nanoparticles. Recent advancements and experimental treatments, such as quorum sensing manipulation and omics integration, offer promising avenues for targeted interventions. In conclusion, this comprehensive review contributes valuable insights for researchers, clinicians, and policymakers in the ongoing battle against antimicrobial resistance. Keywords: ESKAPE; Pathogens; Enterococcus; Biofilm; Antimicrobial resistance